Information
Info for Persons with Reduced Mobility (PRM)
Wheelchairs are available for you and your loved ones. You will need a 1 euro coin. You will find wheelchairs at:    Volunteers’ reception, near the information office in the hospital’s main hall Outside the entrance to the Bucopa building  In the Erasmus covered car park  At the Day Hospital  During the week volunteers are available to assist you when moving around the hospital.  Access and organisation of the hospital are designed for people with reduced mobility
Rich page
Institution
The Erasmus Hospital for care that is accessible to all Since 1977 the Erasmus Hospital has been proposing general care adapted to the individual patient. With a capacity of 1,048 beds, every year it is able to treat between 25,000 and 30,000 hospitalised patients and between 350,000 and 400,000 who attend for consultations as outpatients.    Also recognised as a Belgian reference centre for 12 rare diseases and member of several European reference networks, the hospital is situated on the Erasmus hospital and university campus in Anderlecht. The campus is also home to the Jules Bordet Institute, the Faculty of Medicine of the Université Libre de Bruxelles, the Faculty of Motor Sciences and the School of Public Health.    Two internal centres (the Erasmus Medical Centre – EMC and the Erasmus Imedia Centre), an external polyclinic (Lothier) and two external centres (Trauma and Rehabilitation Centre – CTR and the Geriatric Rehabilitation Centre – CRG) complete the patient care.    The Erasmus Hospital within the Brussels University Hospital (H.U.B.) Since 2021 the Erasmus Hospital has been a part of the Brussels University Hospital (H.U.B.), alongside the Jules Bordet Institute and the Queen Fabiola University Children's Hospital. These three renowned institutions have the same ambition to improve intra-hospital cooperation and to guarantee optimal care pathways while retaining their individual identities. Each is recognised nationally and internationally for their high quality care at the leading edge of technology and for their projects and medical innovation, whether in the field of oncology, paediatrics or specialised treatment. By bringing together these individual hospitals within an umbrella structure, the patient is guaranteed a complete care pathway.    The Erasmus Hospital in figures 1048 beds Between 25 000 and 30 000 hospitalisations a year Between 350 000 and 400 000 consultations a year Our history Since it was founded in 1977, the Erasmus Hospital has continuously developed its activities with the sole aim of guaranteeing high quality care for patients. As a university hospital, the development of infrastructures on the campus is also a priority.    Discover the history of the Erasmus Hospital :  1977 : Inauguration of the Erasmus Hospital and its first 27 beds   1982 : Creation of the Erasmus Fund for medical research   1989 : Signing of the quality charter with the aim of improving the quality of all the hospital's activities, for patients and staff  1991 : Inauguration of the Faculty of Medicine on the campus  2004 : Inauguration of the new Day Hospital   2007 : Inauguration of the Geriatric Day Hospital     2015 : Inauguration of the Lothier Polyclinic in Brussels city centre    2017 : Inauguration of the Trauma and Rehabilitation Centre (CTR) in Laeken    2021 : Grouping of the Erasmus Hospital alongside the Jules Border Institute and Children's Hospital under the name Brussels University Hospital (H.U.B.)    New Erasmus : This major project will make it possible to welcome new modern hospital services while respecting planning and landscaping requirements
Health issues
Interstitial and Diffuse Pneumonias Clinic
What are interstitial pneumonias? Diffuse interstitial pneumonias are a group of relatively rare lung diseases. They are disorders of the lung parenchyma (that is, of the lung itself) with a varying degree of inflammation and fibrosis resulting in a sometimes severe respiratory insufficiency.  The principal pathologies covered by this term are •    Idiopathic pulmonary fibrosis •    Sarcoidosis •    Non-specific interstitial pneumonia •    Cryptogenic organising pneumonia •    Lung disorders secondary to autoimmune diseases (connective tissue disease and vasculitis)  •    Hypersensitivity pneumonitis (farmer‘s lung, bird fancier’s lung •    Some pneumonias of occupational origin (exposure to asbestos or to mineral or metal dust) or drug induced Idiopathic pulmonary fibrosis (IPF) Idiopathic pulmonary fibrosis (IPF) is the most common disease of this group, together with sarcoidosis. The annual incidence is estimated at 10 new cases for 100,000 persons per year and this figure seems to be rising. In IPF the lung is progressively destroyed and replaced by scar tissue. This results in an irreversible and progressive respiratory insufficiency.  Causes and risk factors Its etiology is unknown but smoking, pollution, exposure to certain viruses and the presence of gastroesophageal reflux are risk factors. There are also family forms in which gene mutations have been clearly identified.  IPF affects more men than women and is generally diagnosed at around the age of 60.  Diagnosis and treatment These diseases are rare and therefore demand particular expertise. The diagnosis is complex and requires a multidisciplinary discussion.  In the case of idiopathic pulmonary fibrosis there are two possible treatments: with Esbriet or Ofev. These do not cure the diseases but do make it possible to slow its progress.  If the patient shows no contraindications a lung transplant must be envisaged. In this particular case we work closely together with the lung transplant team. Multidisciplinary meetings are held regularly to discuss complex cases and we have a clinical research unit that permits access to an advanced research programme in this field and patients are invited to participate in international trials to test new treatments.  The Erasmus Hospital is a member of the European experts network in the field of diffuse interstitial pneumonia (ERN lung). We are active in the field of clinical research by providing the opportunity to participate in research protocols and clinical trials.  Finally, we support and participate actively in activities organised by patients’ associations, in particular the   Association Belge Francophone contre la Fibrose Pulmonaire (ABFFP). Useful documents Informations destinées aux patient(e)s Brochure : thérapie par Esbriet (pirfénidone) Brochure : Fibrose Pulmonaire Idiopathique (FPI) Brochure : traitement de votre Fibrose Pulmonaire Idiopathique (FPI) avec OFEV® Requests for opinion Téléchargez le document de demande d'avis de la part du médecin traitant ou spécialiste à destination de la Clinique des pneumopathies interstitielles diffuses. Demande d'avis Multidisciplinary team Découvrez l'équipe multidisciplinaire de la Clinique de Pneumopathies interstitielles et diffuses. Organisation chart Our specialists
Interstitial and Diffuse Pneumonias Clinic
Health issues
Irritable bowel
What is irritable bowel syndrome? Irritable bowel syndrome is a chronic digestive disorder that affects the small and large intestine. Common symptoms are stomach pain and bloating associated with changes in the intestinal transit (constipation or diarrhoea). An estimated 10% of Belgians suffer from this disease. The causes are multiple and examinations (blood tests, imaging, endoscopy) do not show any anomaly.  Clinic The Functional Digestive Disorders Clinic at the Erasmus Hospital proposes a digestive comfort consultation in order to evaluate the situation, relieve symptoms and improve the quality of life of patients. Treatment includes changes to diet, dietary consultation, medication and sometimes physiotherapy as part of a multidisciplinary approach.    Research Innovative tratment is regularly proposed in the framework of clinical trials.    Our specialists Associated service
Irritable bowel